Lamictal and Cleft Palate Birth Defects
The FDA has issued a warning that Lamictal, a GlaxoSmithKline drug prescribed for bipolar disorder and epilepsy, has been linked to birth defects when taken by women in the first three months of pregnancy.
In a registry of 564 pregnant women who took the drug during the first trimester, five gave birth to babies with a cleft lip or cleft palate, which is a gap in the upper lip or roof of the mouth. The agency advises women taking Lamictal who are pregnant or thinking of becoming pregnant to speak with their doctor.
Related: bipolar disorder, epilepsy